RHODOTORULIC ACID

Suppliers

Names

[ CAS No. ]:
18928-00-2

[ Name ]:
RHODOTORULIC ACID

[Synonym ]:
EINECS 242-681-9
N-[3-[5-[3-[acetyl(hydroxy)amino]propyl]-3,6-dioxopiperazin-2-yl]propyl]-N-hydroxyacetamide
Rhodotorulsaeure
(2S-cis)-N,N'-[(3,6-dioxopiperazine-2,5-diyl)di-3,1-propanediyl]bis[N-hydroxyacetamide]
Ethanamine,2,2'-[3,6-acridinediylbis(oxy)]bis[N-methyl
3,6-bis-[3-(acetyl-hydroxy-amino)-propyl]-piperazine-2,5-dione
3,6-bis<2-(methylamino)ethoxy>acridine

Chemical & Physical Properties

[ Density]:
1.277g/cm3

[ Molecular Formula ]:
C14H24N4O6

[ Molecular Weight ]:
344.36400

[ Exact Mass ]:
344.17000

[ PSA ]:
139.28000

[ Vapour Pressure ]:
3.78mmHg at 25°C

[ Index of Refraction ]:
1.423

[ Storage condition ]:
2-8°C

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
AB8132530
CHEMICAL NAME :
Acetamide, N,N'-((3,6-dioxo-2,5-piperazinediyl)di-3,1-propanediy l)bis(N-hydroxy-, (2S-cis)-
CAS REGISTRY NUMBER :
18928-00-2
BEILSTEIN REFERENCE NO. :
0965705
LAST UPDATED :
199701
DATA ITEMS CITED :
3
MOLECULAR FORMULA :
C14-H24-N4-O6
MOLECULAR WEIGHT :
344.42

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
>800 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value

MUTATION DATA

TYPE OF TEST :
DNA inhibition
TEST SYSTEM :
Human Lymphocyte
DOSE/DURATION :
1 mmol/L
REFERENCE :
BCPCA6 Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- Volume(issue)/page/year: 29,1275,1980

Safety Information

[ RTECS ]:
AB8132530

Related Compounds

  • Thiovaleric acid S-sec-butyl ester
  • Octanethioic acid S-propyl ester
  • Hexanethioic acid S-decyl ester
  • Thiopropionic acid S-undecyl ester
  • trisporic acid
  • Benzoic acid, 3,4-dihydroxy-, 2-Methylpropyl ester
  • (2S,3R,4S,5S,6R)-2-[(2R,3R,4S,5S,6R)-2-[[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-17-[(2S)-6-hydroperoxy-6-methyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhept-4-en-2-yl]-12-hydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol
  • Nonacontylbenzene
  • Bottromycamide A1
  • (2S,3R,4S,5S,6R)-2-[(2S)-2-[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-6-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-2-yl]oxy-3,12-dihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-hydroxy-6-methylhept-4-en-2-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol
  • (52S)-Ciguatoxin
  • 1-Trinonacontene
  • Zinc norfloxacin
  • [11,37-Diformyl-4,5,5,14,20,21,22,25,26,30,31,32,44,45,46,49,56-heptadecahydroxy-6,9,17,35,41,53,60-heptaoxo-38-(3,4,5-trihydroxybenzoyl)oxy-2,10,16,28,36,40,54,57,61-nonaoxadecacyclo[37.11.6.413,27.14,50.03,8.018,23.029,34.042,47.048,52.024,59]henhexaconta-1(50),7,18,20,22,24,26,29,31,33,42,44,46,48,51,58-hexadecaen-12-yl] 3,4,5-trihydroxybenzoate
  • 1-Dononacontene
  • (2S,3S,4S,5R,6R)-6-[[(3S,4aR,6aR,6bS,8aR,10S,11S,12R,12aS,14aR,14bR)-8a-carboxy-10-hydroxy-4,4,6a,6b,11,12,14b-heptamethyl-2,3,4a,5,6,7,8,9,10,11,12,12a,14,14a-tetradecahydro-1H-picen-3-yl]oxy]-3,4-dihydroxy-5-[(2S,3R,4S,5S)-3,4,5-trihydroxyoxan-2-yl]oxyoxane-2-carboxylic acid
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.